Quantum Biopharma (QNTM) Capital Expenditures (2022)

Quantum Biopharma's (QNTM) quarterly Capital Expenditures came in at $230839.0 in Q4 2022, up 338.18% quarter-over-quarter from -$96917.0 in Q3 2022.

Quantum Biopharma (QNTM) Capital Expenditures (2022) Analysis & Trends

Quantum Biopharma has disclosed Capital Expenditures across 1 years of filings, most recently posting $230839.0 for Q4 2022.

Capital Expenditures for Q4 2022 came in at $230839.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $113958.0 (changed N/A YoY), and the FY2022 annual result was $113958.0, changed N/A from the prior year.
Capital Expenditures came in at $230839.0 for Q4 2022 at Quantum Biopharma, up from -$96917.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $230839.0 in Q4 2022 to a low of -$96917.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	133.40 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-63,220.27
10	Regeneron Pharmaceuticals	63.43 Bn	54.67 Bn	3.31 Bn	230.60 Mn

Download Data